
Dried Fruit Recall Map Shows 19 States With New Warning
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources.
Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content.
Turkana Food Inc. has issued a recall for their dried apricots because the package label does not disclose that the product contains sulfites.
Newsweek reached out to the company via phone Thursday and left a voicemail.
Why It Matters
Numerous recalls have been initiated this year due to the potential for the following: damaged products, foodborne illness, contamination and undeclared food allergens.
Millions of Americans experience food sensitivities or food allergies every year. According to the Food and Drug Administration (FDA), the nine "major" food allergens in the U.S. are eggs, milk, fish, wheat, soybeans, Crustacean shellfish, sesame, tree nuts and peanuts.
What To Know
According to the FDA alert, the Floria brand dried apricots have an expiration date of November 2026. The impacted product has a LOT number of 440090478-15-333 that can be found at the bottom of the packaging.
The product has a UPC Label of 2539560010 that can be seen on a sticker at the top of the package, the FDA says.
The dried apricots were distributed in Florida, Kentucky, Virginia, New York, New Jersey, Tennessee, Massachusetts, Texas, Illinois, Indiana, Michigan, Rhode Island, Pennsylvania, North Carolina, Maryland, Ohio, Alabama, Missouri and California.
There have been no reported illnesses as of Thursday, the FDA says. The alert also has pictures of the recalled product that potential customers can cross reference.
Below is a map of the impacted states:
What People Are Saying
The FDA alert in part: "The recall was the result of a routine sampling performed by the New York State Department of Agriculture and markets which revealed that the finished products contained Sulfites that were not listed on the product labelling. The company has ceased production and distribution of the products as FDA and the company continue their investigation to correct the issue with the manufacturer."
In an email to Newsweek in January, the FDA said: "Most recalls in the U.S. are carried out voluntarily by the product manufacturer and when a company issues a public warning, typically via news release, to inform the public of a voluntary product recall, the FDA shares that release on our website as a public service.
"The FDA's role during a voluntary, firm-initiated, recall is to review the recall strategy, evaluate the health hazard presented by the product, monitor the recall, and as appropriate alert the public and other companies in the supply chain about the recall," the FDA continued.
It added: "The FDA provides public access to information on recalls by posting a listing of recalls according to their classification in the FDA Enforcement Report, including the specific action taken by the recalling company. The FDA Enforcement Report is designed to provide a public listing of products in the marketplace that are being recalled."
Additional information on recalls can be found via the FDA's Recalls, Market Withdrawals, & Safety Alerts.
What Happens Next
Customers who have purchased the recalled dried apricots are asked not to eat them and return them to the original place of purchase for a refund, the FDA says.
People with additional questions may call Turkana Foods Inc. at 908-810-8800 on weekdays from 8 a.m. to 6 p.m. ET.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Newsweek
16 minutes ago
- Newsweek
Gavin Newsom Reacts to Donald Trump's 'Unprecedented' Medicaid Move
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. California Democratic Governor Gavin Newsom has expressed concern for the privacy of immigrants in his state, following reports that the Trump administration has shared Medicaid data with immigration officials. An internal memo and emails obtained by the Associated Press showed that Medicaid officials unsuccessfully sought to block the data transfer, citing legal and ethical concerns. Nevertheless, two top advisers to Health Secretary Robert F. Kennedy Jr. ordered the dataset handed over to the Department of Homeland Security (DHS), the emails show. Officials at the Centers for Medicare and Medicaid Services (CMS) were given just 54 minutes on Tuesday to comply with the directive. "We deeply value the privacy of all Californians," Newsom's office told Newsweek in a statement. "This action by the federal government has implications for every person on Medicaid, but it is especially alarming for our immigrants and American mixed-status families who are already under relentless, indiscriminate attack by this administration. The federal government continues to instill fear across this nation and shroud its continued violation of Americans' privacy rights in propaganda." Newsweek reached out to DHS and the Department for Health and Human Services for comment via email and contact form Friday afternoon. California Governor Gavin Newsom speaks after U.S. District Judge Charles Breyer granted an emergency temporary restraining order to stop President Donald Trump's deployment of the California National Guard, on June 12, 2025, at the California... California Governor Gavin Newsom speaks after U.S. District Judge Charles Breyer granted an emergency temporary restraining order to stop President Donald Trump's deployment of the California National Guard, on June 12, 2025, at the California State Supreme Court building in San Francisco. More Santiago Mejia/San Francisco Chronicle via AP Why It Matters Reports of increased data sharing between federal agencies for the purpose of immigration enforcement have caused concerns for several weeks. The Trump administration has said the data is vital in finding illegal immigrants who should be deported. What To Know The dataset included the information of people living in California, Illinois, Washington state and Washington, D.C., all of which allow non-U.S. citizens to enroll in Medicaid programs that pay for their expenses using only state taxpayer dollars. CMS transferred the information just as the Trump administration was ramping up its enforcement efforts in Southern California. Newsom's office said it was concerned about how deportation officials might utilize the data, especially as federal authorities conduct immigration raids with the assistance of National Guard troops and Marines in Los Angeles. Besides helping authorities locate migrants, experts said, the government could also use the information to scuttle the hopes of migrants seeking green cards, permanent residency or citizenship if they had ever obtained Medicaid benefits funded by the federal government. CMS announced late last month that it was reviewing some states' Medicaid enrollees to ensure federal funds have not been used to pay for coverage for people with "unsatisfactory immigration status." In a letter sent to state Medicaid officials, CMS said that the effort was part of Trump's February 19 executive order titled "Ending Taxpayer Subsidization of Open Borders." As part of the review, California, Washington and Illinois shared details about non-U.S. citizens who have enrolled in their state's Medicaid program, according to a June 6 memo signed by Medicaid Deputy Director Sara Vitolo that was obtained by AP. The memo was written by several CMS officials under Vitolo's supervision, according to sources familiar with the process. The data includes addresses, names, Social Security numbers and claims data for enrollees in those states, according to the memo and two people familiar with what the states sent to CMS. Both people spoke on the condition of anonymity because they were not authorized to share details about the data exchange. CMS officials attempted to fight the data sharing request from Homeland Security, saying that complying would violate federal laws, including the Social Security Act and the Privacy Act of 1974, according to Vitolo's memo. "Multiple federal statutory and regulatory authorities do not permit CMS to share this information with entities outside of CMS," Vitolo wrote, further explaining that the sharing of such personal data is allowed only for directly administering the Medicaid program. Sharing information about Medicaid applicants or enrollees with DHS officials would violate a "longstanding policy," wrote Vitolo, a career employee, to Trump appointee Kim Brandt, deputy administrator and chief operating officer of CMS. The legal arguments outlined in the memo were not persuasive to Trump appointees at HHS, which oversees Medicaid. Four days after the memo was sent, on June 10, HHS officials directed the transfer of "the data to DHS by 5:30 ET today," according to email exchanges obtained by AP. Former government officials said the move was unusual because CMS, which has access to personal health data for nearly half of the country, does not typically share such sensitive information with other departments. "DHS has no role in anything related to Medicaid," said Jeffrey Grant, a former career employee at CMS. Beyond her legal arguments, Vitolo said sharing the information with DHS could have a chilling effect on states, perhaps prompting them to withhold information. States, she added, needed to guard against the "legal risk" they were taking by giving federal officials data that could be shared with deportation officials. A 'Concerning' Development All states must legally provide emergency Medicaid services to non-U.S. citizens, including to those who are lawfully present but have not yet met a five-year wait to apply for Medicaid. Seven states, along with the District of Columbia, allow immigrants who are not living legally in the country to enroll—with full benefits—in their state's Medicaid program. The states launched these programs during the Biden administration and said they would not bill the federal government to cover those immigrants' health care costs. The Trump administration has raised doubts about that pledge. Nixon said that the state's Medicaid programs for immigrants "opened the floodgates for illegal immigrants to exploit Medicaid—and forced hard-working Americans to foot the bill." All of the states—California, New York, Washington, Oregon, Illinois, Minnesota and Colorado—have Democratic governors. As a result of his state's budget woes, Newsom announced earlier this year that he would freeze enrollment in the program. Illinois will shut down its program for roughly 30,000 non-U.S. citizens in July. The remaining states have not yet submitted the identifiable data to CMS as part of the review, according to a public health official who has reviewed CMS' requests to the states. What People Are Saying U.S. Health and Human Services spokesman Andrew Nixon told AP that the data sharing was legal: "With respect to the recent data sharing between CMS and DHS, HHS acted entirely within its legal authority—and in full compliance with all applicable laws—to ensure that Medicaid benefits are reserved for individuals who are lawfully entitled to receive them." California Governor Gavin Newsom's office, in a statement sent to Newsweek: "Sharing Medicaid beneficiary information with the Department of Homeland Security—which is itself legally dubious—will jeopardize the safety, health, and security of those who will undoubtedly be targeted by this abuse, and Americans more broadly. "Federal law requires emergency care to be provided to all to save lives, and the federal government helps pay for it for low-income individuals, regardless of immigration status. Every state should be concerned about this data sharing and its implications for the safety and health of its communities. We will continue to vigorously defend Californians' privacy rights and explore all avenues to protect their information and safety." What Happens Next Republicans in Congress are continuing to look to limit undocumented immigrants from accessing federal programs while continuing to scrutinize whether sanctuary jurisdictions allow them to receive benefits. This article contains reporting by The Associated Press.
Yahoo
17 minutes ago
- Yahoo
Urgent dried fruit recall in 19 states over serious health risk
Dried fruit sold in multiple states has been recalled due to a serious health risk. Turkana Food Inc issued a recall on 352 cases of its Floria Dried Apricots, according to a press release shared by the U.S. Food and Drug Administration on Thursday. The product was recalled because it contains an undeclared allergen, sulfites, or 'chemicals used as preservatives' added to foods, beverages, and medications to prevent them from spoiling, according to the Cleveland Clinic. According to the FDA, the recall came after routine sampling, performed by the New York State Department of Agriculture, revealed that the product contained sulfites, which 'were not listed on the product labeling.' As Turkana Food Inc continues an 'investigation to correct the issue with the manufacturer,' production and distribution of the product by the FDA has been ceased. The recalled Floria Dried Apricots were sold at stores in 19 states: Alabama, California, Florida, Illinois, Indiana, Kentucky, Massachusetts, Maryland, Michigan, Missouri, New Jersey, New York, North Carolina, Ohio, Pennsylvania, Rhode Island, Tennessee, Texas, and Virginia. The product has the LOT number 440090478-15-333 on the bottom portion of the packaging. The UPC Label 2539560010 is marked by a sticker on the side of the packaging. The expiration date of November 2026 is also on the bottom of the packaging. Consumers who have the recalled product should not consume it. The FDA is also urging consumer to return the dried apricots to the place of purchase for a full refund. There have been no reported illnesses so far. Most often, people with asthma have allergies and sensitivities to sulfites. Earlier this week, P. East Trading Corp. also urgently recalled its Salted Smoked Split Herring because it may have been contaminated with Clostridium botulinum, a bacterium that can cause illness or death. Botulism is a rare but serious condition caused by a toxin that attacks the body's nerves. Symptoms include general weakness, dizziness, double-vision, trouble with speaking or swallowing, difficulty in breathing, abdominal distension, and constipation. Then, on Tuesday, 6,668 cases of Breyers Chocolate Truffle Ice Cream was also recalled following customer concerns that there was a mislabeling error. The recall came after it was found that the tubs actually contained Rocky Road ice cream. The Chocolate Truffle flavor has an allergen label that reads, 'may contain tree nuts,' while the Rocky Road flavor declares almonds as one of the ingredients. The last two years have also seen an alarming and unexplained rise in recalls. In 2024, approximately 300 food recalls were issued, with those recalls being linked to nearly 1,400 illnesses, a Public Interest Research Group report revealed. Out of the 1,400 illnesses, 487 people became sick enough to require hospitalization, and 19 people died. While those numbers are still low when weighed against the entire U.S. population, they are also double the number of hospitalizations and deaths from food-borne illnesses in 2023.
Yahoo
19 minutes ago
- Yahoo
Insmed Incorporated (INSM) Soars on Positive PAH Therapy Trial Results
Insmed Incorporated (NASDAQ:INSM) is among the 10 Best Growth Stocks Under $100 to Buy Now. The shares of Insmed Incorporated (NASDAQ:INSM) have witnessed a surge of about 32% in the course of five days following the success of Phase 2b of its once-daily pulmonary arterial hypertension (PAH) therapy, treprostinil palmitil inhalation powder (TPIP). The results were evaluated about 24 hours after the administration of the drug, showcasing a consistent benefit throughout the 24-hour dosing period. Additionally, the company has revealed plans to initiate discussions with the U.S. Food and Drug Administration (FDA) to shape its Phase 3 trials roadmap. While this first Phase 3 trial will focus on pulmonary hypertension tied to interstitial lung disease by the year's end, the second trial is designed for PAH patients in the coming year. By 2032, the global market for pulmonary arterial hypertension is set to climb to $12.2 billion. A biopharmaceutical research team taking notes in front of a laboratory's microscope. The two anticipated phase 3 studies are enough to be excited about the company, yet there exists another breakthrough. Insmed Incorporated (NASDAQ:INSM) has finalized and submitted its New Drug Application (NDA) of brensocatib for treating patients with Non-cystic fibrosis bronchiectasis (NCFBE), with the date for review set for August 12, 2025. The company is indeed among the companies with high growth potential. Insmed Incorporated (NASDAQ:INSM) is a New Jersey-based biopharmaceutical company that develops and markets therapies to treat patients with serious and rare diseases. With a global presence, the company is committed to transforming the lives of many. While we acknowledge the potential of INSM as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None.